IP Library Granted Patent US 7,126,003
Granted Patent B2
US 7,126,003 · App. 10/469,918 · Granted Oct 24, 2006

Method for producing 2-azetidinone derivative

Assignee: Daiichi Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,126,003
App. No.
10/469,918
Granted
Oct 24, 2006
Kind
B2
Abstract

A process for producing a compound represented by the following formula (II) which comprises treating a compound represented by the following formula (I) (wherein R 1 , R 2 and R 3 represent each a specific substituent) with an enzyme capable of asymmetrically hydrolyzing an ester and the novel compound (II). The process of the present invention makes it possible to easily obtain an optically active 2-azetidinone derivative in a large amount at a low cost

Claims (17)

1. A process for producing a compound represented by formula (II):

wherein R 1 represents a 3-fluoro-2-pyridyl group; R2 represents a hydrogen atom, a hydroxyl group, an alkoxyl group having 1 to 6 carbon atoms which may have substituent(s), an alkanoyl group having 1 to 6 carbon atoms which may have substituent(s), an alkenoyl group having 2 to 6 carbon atoms which may have substituent(s), an aryl group which may have substituent(s), an aryloyl group which may have substituent(s) or an aralkyl group which may have substituent(s); and R3 represents an alkyl group having 1 to 6 carbon atoms which may have substituent(s) or an alkenyl group having 2 to 6 carbon atoms which may have substituent(s);

which comprises treating a compound represented by

formula (I) with an enzyme capable of asymmetrically hydrolyzing an ester:

wherein R 1 , R 2 and R 3 are each as defined above.

2. The process according to claim 1 wherein R 2 is a phenyl group (which may have one or more substituent(s) selected from the group consisting of a halogen atom, an alkyl group having 1 to 6 carbon atoms, a halogenoalkyl group having 1 to 6 carbon atoms, an alkoxyl group having 1 to 6 carbon atoms, a nitro group, a carbamoyl group and a cyano group) or an aralkyl group (having a structure wherein an alkyl group having 1 to 6 carbon atoms is substituted by one or more aryl group(s); and said aryl moiety may have one or more substituent(s) selected from the group consisting of a halogen atom, an alkyl group having 1 to 6 carbon atoms, a halogenoalkyl group having 1 to 6 carbon atoms, an alkoxyl group having 1 to 6 carbon atoms, a nitro group, a carbamoyl group and a cyano group).

3. The process according to claim 1 wherein R 2 is a 4-methoxyphenyl group or a bis(4-methoxyphenyl)methyl group.

4. The process according to claim 1 wherein R 3 is a methyl group.

5. The process according to claim 1 wherein the enzyme is a lipase.

6. The process according to claim 5 wherein the lipase is a lipase originating in a microorganism belonging to the genus Pseudomonas.

7. The process according to claim 5 wherein the lipase is a lipase originating in a microorganism belonging to the genus Aspergillus.

8. The process according to claim 6 or 7 wherein the lipase is immobilized.

9. A compound represented by formula (II):

wherein R 1 represents a 3-fluoro-2-pyridyl group; R 2 represents a hydrogen atom, a hydroxyl group, an alkoxyl group having 1 to 6 carbon atoms which may have substituent(s), an alkanoyl group having 1 to 6 carbon atoms which may have substituent(s), an alkenoyl group having 2 to 6 carbon atoms which may have substituent(s), an aryl group which may have substituent(s), an aryloyl group which may have substituent(s) or an aralkyl group which may have substituent(s); and R 3 represents an alkyl group having 1 to 6 carbon atoms which may have substituent(s) or an alkenyl group having 2 to 6 carbon atoms which may have substituent(s).

10. The compound according to claim 9 wherein R 2 is a phenyl group (which may have one or more substituent(s) selected from the group consisting of a halogen atom, an alkyl group having 1 to 6 carbon atoms, a halogenoalkyl group having 1 to 6 carbon atoms, an alkoxyl group having 1 to 6 carbon atoms, a nitro group, a carbamoyl group and a cyano group) or an aralkyl group (having a structure wherein an alkyl group having 1 to 6 carbon atoms is substituted by one or more aryl group(s); and said aryl moiety may have one or more substituent(s) selected from the group consisting of a halogen atom, an alkyl group having 1 to 6 carbon atoms, a halogenoalkyl group having 1 to 6 carbon atoms, an alkoxyl group having 1 to 6 carbon atoms, a nitro group, a carbamoyl group and a cyano group).

11. The compound according to claim 9 wherein R 2 is a 4-methoxyphenyl group or bis(4-methoxyphenyl)methyl group.

12. The compound according to claim 9 wherein R 3 is a methyl group.

Assignments (2)
MERGER Recorded Aug 1, 2017
From: DAIICHI PHARMACEUTICAL CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 043760/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2003
From: SATO, KOUJI; YAGI, TSUTOMU; KITAGAWA, YUTAKA; ICHIKAWA, SHIGERU; IMURA, AKIHIRO
To: DAIICHI PHARMACEUTICAL CO., LTD.
Reel/Frame 014816/0539 →
Priority Claims (1)
JP 2001-63840 · Mar 7, 2001 · national
Continuity (1)
Related Publication 20040072309A1 · Apr 15, 2004